KALAMAZOO, Mich.--(BUSINESS WIRE)--Stryker (NYSE:SYK) today announced the launch of Citrefix™, a suture anchor system for foot and ankle surgical procedures. The new system uses Citregen™, an award-winning bioresorbable material designed...
DEERFIELD, Ill., Dec. 13, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of...
SpineGuard (FR0011464452 – ALSGD) (Paris:ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) sensing technology to secure and streamline the placement of bone implants, announced today that two researchers,...
CLEVELAND--(BUSINESS WIRE)--A new study conducted by University Hospitals Health System (UH) comparing the time it takes to set up and take down a traditional wired arthroscopic camera system in an...
Canary Quantiles™ Recovery Curves Compare Observed Gait Performance versus Population Gait Performance During a Patient’s Recovery from Total Knee Replacement Surgery Quantiles™ Recovery Curves Utilize Data Derived from Persona IQ® to Help Healthcare Professionals with...
ROSEMONT, Ill., Dec. 8, 2022 /PRNewswire/ --The American Academy of Orthopaedic Surgeons (AAOS) today announced the Fracture & Trauma Registry (FTR) will now be powered by PatientIQ. This new partnership will offer healthcare institutions a...
Arthrex Bunionectomy offers better results with faster recovery than traditional surgery NAPLES, Fla., Dec. 5, 2022 /PRNewswire/ -- Arthrex, a global leader in minimally invasive orthopedic technology, has launched the award-winning Arthrex Minimally Invasive Bunionectomy...
Co-developed by neurosurgeons from Hoag's Pickup Family Neurosciences Institute, SyncAR for Spine receives FDA-clearance NEWPORT BEACH, Calif., Dec. 7, 2022 /PRNewswire/ -- Hoag's innovative spine team has performed the first spinal fusion surgery...
Study results demonstrate NVD-003 has a favorable safety profile and convincing efficacy including rapid, durable bone healing in patients following failure of conventional treatment Clinical data will inform development of the Company’s...
MELVILLE, N.Y., Dec. 05, 2022 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative” or the “Company”) (NASDAQ: BRTX), a clinical stage company focused on stem cell-based therapies, today announced an agreement with Regenexx, LLC pursuant to which the...